Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the United States Patent and Trademark...

Related Keywords

United States ,American ,Brianm Culley , ,Roche Group ,Exchange Commission ,Genentech ,Trademark Office ,Lineage Cell Therapeutics Inc ,Lineage Cell Therapeutics ,United States Patent ,Scale Production ,Retinal Pigment Epithelial ,Cell Therapeutics ,Annual Report ,Markets ,